ArticleBMJ open2022

Proactive infliximab optimisation using a pharmacokinetic dashboard versus standard of care in patients with Crohn's disease: study protocol for a randomised, controlled, multicentre, open-label study (the OPTIMIZE trial).

Konstantinos Papamichael et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.